[SLRX] YoY Quarter Result on 31-Dec-2016 [#Q4]

Stock
[SLRX] Salarius Pharmaceuticals, Inc.
Announcement Date
08-Mar-2017
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- 25.73%
YoY- -0.09%
Quarter Report
SLRX's Result
SLRX's Financial Summary
View:
Show?
Quarter Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 1,479 1,039 163 283 299 0 0 -
PBT -1,768 -1,882 -2,009 -8,029 -7,900 -7,893 -3,742 -11.73%
Tax 10 1 -51 -74 -112 -15 0 -
NP -1,768 -1,883 -2,009 -8,029 -7,900 -7,893 -3,742 -11.73%
Tax Rate - - - - - - - -
Total Cost 3,246 2,922 2,172 8,312 8,199 7,893 3,742 -2.33%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin -119.52 -181.27 -1,232.52 -2,837.10 -2,642.14 0.00 0.00 -
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -2.84 -14.40 -69.50 -284.43 -297.08 -317.20 -137.41 -47.58%
EPS Diluted -2.84 -14.40 -69.50 -284.43 -297.08 -317.20 -137.41 -47.58%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.